Abstract
To gain a more accurate understanding of the current real-world management of dyslipidemia in Japan, an online survey was conducted in a variety of physicians from five medical fields. A web-based survey with online questionnaire was designed, and members of an on-line information service for physicians were invited to participate. The survey enrolled 500 physicians, 100 in each of five categories: cardiology; diabetes, metabolism and endocrinology; neurology/neurosurgery/stroke medicine; general internal medicine (hospitals ≥20 beds), and general internal medicine (self-employed practitioners at clinics or small hospitals ≤19 beds). Regardless of their specialties, most physicians recognized high low density lipoprotein cholesterol level as an important risk for atherosclerotic cardiovascular disease. Physicians with expertise in cardiology, diabetes, metabolism and endocrinology were most in favor of drug-based cholesterol lowering. Specialists in neurology/neurosurgery/stroke medicine and in general internal medicine were more concerned about statin safety and aggressive lipid-lowering therapy than those in cardiology and diabetes, metabolism and endocrinology, and tended to treat fewer patients with familial hypercholestero...Continue Reading
References
Apr 6, 1989·The New England Journal of Medicine·H IsoJ D Cohen
Mar 26, 2003·Circulation Journal : Official Journal of the Japanese Circulation Society·Yuji MatsuzawaUNKNOWN J-LIT Study Group
Mar 10, 2005·The New England Journal of Medicine·John C LaRosaUNKNOWN Treating to New Targets (TNT) Investigators
Nov 17, 2005·JAMA : the Journal of the American Medical Association·Terje R PedersenUNKNOWN Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Study Group
Oct 3, 2006·Lancet·Haruo NakamuraUNKNOWN MEGA Study Group
Apr 15, 2009·Circulation·Hiroyuki NodaHitoshi Ohta
Nov 12, 2010·Lancet·UNKNOWN Cholesterol Treatment Trialists’ (CTT) CollaborationR Collins
May 15, 2013·Journal of Atherosclerosis and Thrombosis·Tamio TeramotoUNKNOWN Japan Atherosclerosis Society
Aug 21, 2013·European Heart Journal·Børge G NordestgaardUNKNOWN European Atherosclerosis Society Consensus Panel
Mar 1, 2005·Current Therapeutic Research, Clinical and Experimental·Tamio Teramoto J-Lap Investigators
Jul 16, 2016·Atherosclerosis·Tamio TeramotoShizuya Yamashita
Aug 30, 2016·Journal of Atherosclerosis and Thrombosis·Hayato TadaKenshi Hayashi
Jun 28, 2017·Journal of Atherosclerosis and Thrombosis·UNKNOWN Joint Committee for Comprehensive Risk Management Chart for the Prevention of Cerebro- Cardiovascular Diseases
Dec 15, 2017·Journal of Atherosclerosis and Thrombosis·Kazuyo TsushitaKozo Tatara
Feb 23, 2018·Journal of Atherosclerosis and Thrombosis·Yuji Matsuzawa